The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of patients (pts) treated with novel immunotherapy (IT) agents in phase 1 clinical trials (Ph1-CT) at early lines for advanced disease.
 
Juan José Soto
Speakers' Bureau - Novartis; PharmaMar
 
Carlos Erasun Lecuona
Employment - Pierre Fabre
 
Sandra Llop Serna
No Relationships to Disclose
 
Nuria Mulet Margalef
No Relationships to Disclose
 
Agostina Stradella
Consulting or Advisory Role - Eisai; Roche
Speakers' Bureau - Eisai; Roche
Travel, Accommodations, Expenses - Pfizer; Roche
 
Rafael Villanueva
Consulting or Advisory Role - Novartis
Speakers' Bureau - Lilly; Novartis
Expert Testimony - Novartis
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Eisai; Lilly; Novartis; Roche
 
Mariona Calvo Campos
Consulting or Advisory Role - Bayer; Eisai; MSD; Roche
 
Maria Jove Casulleras
Speakers' Bureau - MSD; Roche
Travel, Accommodations, Expenses - MSD; Roche
 
Carmen Cuadra Amor
No Relationships to Disclose
 
Ramon Salazar Soler
Leadership - Sace Medhealth
Stock and Other Ownership Interests - Sace Medhealth
Consulting or Advisory Role - Amgen; Amgen; AstraZeneca; Celgene; Guardant Health; Ipsen; Lilly; Merck; Merck Serono; MSD; Novartis; Pfizer; Roche; Roche; VCN Biosciences
Speakers' Bureau - Amgen; Novartis; Roche
Research Funding - Roche
Travel, Accommodations, Expenses - Amgen; Ipsen; Merck; Novartis; Roche
 
Marta Gil-Martin
Speakers' Bureau - AstraZeneca Spain; MSD
 
Juan Martin-Liberal
Consulting or Advisory Role - Bristol-Myers Squibb; Highlight Therapeutics; Novartis; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; MSD; Novartis; Pfizer; Pierre Fabre; Roche
 
Marc Oliva
Honoraria - Merck; MSD Oncology; Transgene
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Pfizer; Merck; MSD Oncology
Other Relationship - Bristol-Myers Squibb; Merck; MSD Oncology